PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the setup of a €10 million loan granted by its top shareholder, Financière de la Montagne. A BioAlliance Pharma shareholder since 2008, today its top